Beijing Tong Ren Tang WM Dianorm Biotech Co., Limited announced that it entered into agreement that it will receive CNY 33,345,000 in an equity round of funding on February 16, 2023. The transaction will include participation from new investor Jianzhijia Pharmaceutical Chain Group Co., Ltd. for 25% stake in the company. The $1,000,000 will go to registered capital and the remaining amount to capital reserve, and its registered capital will increase from $3,000,000 to $4,000,000.

The company does not need the approvals of the Company?s Directorate and Shareholders.